Literature DB >> 16431342

Digital ulcers in patients with systemic sclerosis.

Lorinda Chung1, David Fiorentino.   

Abstract

Digital ulcers (DU), defined as necrotic lesions located at distal digits or overlying bony prominences, occur in up to 50% of patients with limited or diffuse systemic sclerosis (SSc). These lesions are extremely painful and lead to substantial functional disability. The pathogenesis of DU differs depending on their location. DU located at distal aspects of digits are thought to be related to tissue ischemia from several processes, including vasospasm secondary to Raynaud's phenomenon, intimal fibro-proliferation, and thrombosis of digital arteries. DU located over bony prominences, such as the phalangeal joints and elbows, are thought to be due to repetitive microtrauma and difficulty healing due to atrophic, avascular tissue overlying the joints. Management of DU include non-pharmacologic and pharmacologic modalities. This review summarizes the current available and investigational therapies for the treatment and prevention of DU in patients with SSc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16431342     DOI: 10.1016/j.autrev.2005.08.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  18 in total

1.  Successful treatment of scleroderma-related cutaneous ulcer with suction blister grafting.

Authors:  Yoshiro Ichiki; Yasuo Kitajima
Journal:  Rheumatol Int       Date:  2007-08-08       Impact factor: 2.631

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

Review 3.  Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors:  Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

4.  Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis.

Authors:  Murray Baron; Lorinda Chung; Geneviève Gyger; Laura Hummers; Dinesh Khanna; Maureen D Mayes; Janet E Pope; Ami A Shah; Virginia D Steen; Russell Steele; Solène Tatibouet; Ariane Herrick; Ulf Müller-Ladner; Marie Hudson
Journal:  Clin Rheumatol       Date:  2013-12-20       Impact factor: 2.980

5.  Genistein protects dermal fibrosis in bleomycin-induced experimental scleroderma.

Authors:  Süleyman Serdar Koca; Adile Ferda Dağlı; Servet Yolbaş; Nevzat Gözel; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2015-05-20

6.  Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells.

Authors:  Eliza R Pelrine; Marie-Dominique Ah-Kioon; Meng Zhang; Franck J Barrat; Robert F Spiera; Jessica K Gordon
Journal:  HSS J       Date:  2016-07-22

7.  Digital gangrene associated with anticentromere antibodies: a case report.

Authors:  Lauren Bolster; Regina M Taylor-Gjevre; Bindu Nair; John A Gjevre
Journal:  J Med Case Rep       Date:  2010-06-22

8.  Digital ulcers in scleroderma patients: A retrospective observational study.

Authors:  A De Cata; M Inglese; F Molinaro; S De Cosmo; R Rubino; M Bernal; G Mazzoccoli
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

9.  Registry evaluation of digital ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Marco Matucci-Cerinic
Journal:  Int J Rheumatol       Date:  2010-08-25

10.  Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.

Authors:  F Cozzi; E Pigatto; M Rizzo; M Favaro; E Zanatta; S Cardarelli; L Riato; L Punzi
Journal:  Clin Rheumatol       Date:  2013-01-24       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.